About me
Alissa Mun is a Health Scientist Policy Analyst in the Division of Clinical Trial Quality of the Office of Medical Policy in CDER/FDA. She provides scientific and technical input for ongoing policy initiatives such as risk-based monitoring, quality by design, and risk management with drug development. She has been at the FDA since September of 2023. Before joining the FDA, she was the Section Chief of the Clinical Research Quality Management Section in the Office of Research Support and Compliance at the NIH Clinical Center. Ms. Mun earned her Master in Science from Drexel University and is a certified ACRP-CP.
